PetVivo Holdings Inc. Warrant

NASDAQ:PETVW USA Medical Devices
Market Cap
$93.76
Market Cap Rank
#38745 Global
#12579 in USA
Share Price
$0.01
Change (1 day)
-63.64%
52-Week Range
$0.01 - $0.06
All Time High
$0.06
About

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for … Read more

PetVivo Holdings Inc. Warrant (PETVW) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.525x

Based on the latest financial reports, PetVivo Holdings Inc. Warrant (PETVW) has a cash flow conversion efficiency ratio of -0.525x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.19 Million) by net assets ($4.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

PetVivo Holdings Inc. Warrant - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how PetVivo Holdings Inc. Warrant's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

PetVivo Holdings Inc. Warrant Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PetVivo Holdings Inc. Warrant ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for PetVivo Holdings Inc. Warrant (2011–2025)

The table below shows the annual cash flow conversion efficiency of PetVivo Holdings Inc. Warrant from 2011 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $4.22 Million $-5.32 Million -1.261x +88.34%
2024-03-31 $685.95K $-7.42 Million -10.816x -15.42%
2023-03-31 $725.02K $-6.79 Million -9.371x -1243.82%
2022-03-31 $5.99 Million $-4.17 Million -0.697x -159.73%
2021-03-31 $-896.98K $-1.05 Million 1.168x +143.63%
2020-03-31 $-1.04 Million $-496.59K 0.479x -45.02%
2019-03-31 $-844.82K $-736.45K 0.872x +120.57%
2018-03-31 $136.65K $-579.15K -4.238x -2329.30%
2017-03-31 $819.75K $-143.02K -0.174x -284.41%
2016-03-31 $15.21 Million $-690.33K -0.045x +98.16%
2015-03-31 $161.25K $-398.48K -2.471x -440.34%
2014-03-31 $-301.81K $-219.13K 0.726x +90.00%
2013-03-31 $-184.51K $-70.51K 0.382x +37.56%
2012-03-31 $-177.62K $-49.34K 0.278x -87.92%
2011-03-31 $-74.99K $-172.42K 2.299x --